{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:38:45Z","timestamp":1792042725152,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:00Z","timestamp":1597449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:00Z","timestamp":1597449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Unitaid","award":["Market intervention to accelerate uptake of new vector control tools"],"award-info":[{"award-number":["Market intervention to accelerate uptake of new vector control tools"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>S\u00e9gou Region in central Mali is an area of high malaria burden with seasonal transmission. The region reports high access to and use of long-lasting insecticidal nets (LLINs), though the principal vector, <jats:italic>Anopheles gambiae<\/jats:italic>, is resistant to pyrethroids. From 2011 until 2016, several high-burden districts of S\u00e9gou also received indoor residual spraying (IRS), though in 2014 concerns about pyrethroid resistance prompted a shift in IRS products to a micro-encapsulated formulation of the organophosphate insecticide pirimiphos-methyl. Also in 2014, the region expanded a pilot programme to provide seasonal malaria chemoprevention (SMC) to children aged 3\u201359\u00a0months in two districts. The timing of these decisions presented an opportunity to estimate the impact of both interventions, deployed individually and in combination, using quality-assured passive surveillance data.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A non-randomized, quasi-experimental time series approach was used to analyse monthly trends in malaria case incidence at the district level. Districts were stratified by intervention status: an SMC district, an IRS district, an IRS\u2009+\u2009SMC district, and control districts that received neither IRS nor SMC in 2014. The numbers of positive rapid diagnostic test (RDT\u2009+) results reported at community health facilities were aggregated and epidemiological curves showing the incidence of RDT-confirmed malaria cases per 10,000 person-months were plotted for the total all-ages and for the under 5\u00a0year old (u5) population. The cumulative incidence of RDT\u2009+\u2009malaria cases observed from September 2014 to February 2015 was calculated in each intervention district and compared to the cumulative incidence reported from the same period in the control districts.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Cumulative peak-transmission all-ages incidence was lower in each of the intervention districts compared to the control districts: 16% lower in the SMC district; 28% lower in the IRS district; and 39% lower in the IRS\u2009+\u2009SMC district. The same trends were observed in the u5 population: incidence was 15% lower with SMC, 48% lower with IRS, and 53% lower with IRS\u2009+\u2009SMC. The SMC-only intervention had a more moderate effect on incidence reduction initially, which increased over time. The IRS-only intervention had a rapid, comparatively large impact initially that waned over time. The impact of the combined interventions was both rapid and longer lasting.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Evaluating the impact of IRS with an organophosphate and SMC on reducing incidence rates of passive RDT-confirmed malaria cases in S\u00e9gou Region in 2014 suggests that combining the interventions had a greater effect than either intervention used individually in this high-burden region of central Mali with pyrethroid-resistant vectors and high rates of household access to LLINs.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12936-020-03361-y","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T13:02:39Z","timestamp":1597496559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Combining next-generation indoor residual spraying and drug-based malaria control strategies: observational evidence of a combined effect in Mali"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5178-3098","authenticated-orcid":false,"given":"Joseph","family":"Wagman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idrissa","family":"Ciss\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diakalkia","family":"Kone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seydou","family":"Fomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Mihigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Bankineza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamadou","family":"Bah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diadier","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Gogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzie","family":"Tynuv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Saibu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christen","family":"Fornadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Slutsker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,15]]},"reference":[{"key":"3361_CR1","volume-title":"Global technical strategy for malaria: 2016\u20132030","author":"WHO","year":"2015","unstructured":"WHO. Global technical strategy for malaria: 2016\u20132030. Geneva: World Health Organization; 2015."},{"key":"3361_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207\u201311.","journal-title":"Nature"},{"key":"3361_CR3","doi-asserted-by":"publisher","first-page":"e1002450","DOI":"10.1371\/journal.pmed.1002450","volume":"14","author":"malERA Refresh Consultative Panel","year":"2017","unstructured":"malERA Refresh Consultative Panel. malERA: an updated research agenda for insecticide and drug resistance in malaria elimination and eradication. PLoS Med. 2017;14:e1002450.","journal-title":"PLoS Med"},{"key":"3361_CR4","volume-title":"World malaria report 2017","author":"WHO","year":"2017","unstructured":"WHO. World malaria report 2017. Geneva: World Health Organization; 2017."},{"key":"3361_CR5","doi-asserted-by":"publisher","first-page":"e1002453","DOI":"10.1371\/journal.pmed.1002453","volume":"14","author":"malERA Refresh Consultative Panel","year":"2017","unstructured":"malERA Refresh Consultative Panel. An updated research agenda for combination interventions and modelling in malaria elimination and eradication. PLoS Med. 2017;14:e1002453.","journal-title":"PLoS Med"},{"key":"3361_CR6","volume-title":"Guidelines for malaria vector control","author":"WHO","year":"2017","unstructured":"WHO. Guidelines for malaria vector control. Geneva: World Health Organization; 2017."},{"key":"3361_CR7","volume-title":"Policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa","author":"WHO","year":"2012","unstructured":"WHO. Policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: World Health Organization; 2012."},{"key":"3361_CR8","volume-title":"Indoor residual spraying: an operational manual for IRS for malaria transmission control and elimination","author":"WHO","year":"2015","unstructured":"WHO. Indoor residual spraying: an operational manual for IRS for malaria transmission control and elimination. 2nd ed. Geneva: World Health Organization; 2015.","edition":"2"},{"key":"3361_CR9","volume-title":"Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in children: a field guide","author":"WHO","year":"2013","unstructured":"WHO. Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in children: a field guide. Geneva: World Health Organization; 2013."},{"key":"3361_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/j.1365-3156.2004.01263.x","volume":"9","author":"MLH Mabaso","year":"2004","unstructured":"Mabaso MLH, Sharp B, Lengeler C. Historical review of malaria control in southern Africa with emphasis on the use of indoor residual house-spraying. Trop Med Int Health. 2004;9:846\u201356.","journal-title":"Trop Med Int Health"},{"key":"3361_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12936-017-2168-2","volume":"17","author":"J Wagman","year":"2018","unstructured":"Wagman J, Gogue C, Tynuv K, Mihigo J, Bankineza E, Bah M, et al. An observational analysis of the impact of indoor residual spraying with non-pyrethroid insecticides on the incidence of malaria in Segou Region, Mali: 2012\u20132015. Malar J. 2018;17:19.","journal-title":"Malar J"},{"key":"3361_CR12","doi-asserted-by":"publisher","first-page":"e0151971","DOI":"10.1371\/journal.pone.0151971","volume":"11","author":"M Kanyangarara","year":"2016","unstructured":"Kanyangarara M, Mamini E, Mharakurwa S, Munyati S, Gwanzura L, Kobayashi T, et al. Reduction in malaria incidence following indoor residual spraying with Actellic 300 CS in a setting with pyrethroid resistance: Mutasa District, Zimbabwe. PLoS ONE. 2016;11:e0151971.","journal-title":"PLoS ONE"},{"key":"3361_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12936-016-1143-7","volume":"15","author":"B Hamainza","year":"2016","unstructured":"Hamainza B, Sikaala CH, Moonga HB, Chanda J, Chinula D, Mwenda M, et al. Incremental impact upon malaria transmission of supplementing pyrethroid-impregnated long-lasting insecticidal nets with indoor residual spraying using pyrethroids or the organophosphate, pirimiphos methyl. Malar J. 2016;15:100.","journal-title":"Malar J"},{"key":"3361_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/trstmh\/trv089","volume":"109","author":"SE Wragge","year":"2015","unstructured":"Wragge SE, Toure D, Coetzee M, Gilbert A, Christian R, Segoea G, et al. Malaria control at a gold mine in Sadiola District, Mali, and impact on transmission over 10 years. Trans R Soc Trop Med Hyg. 2015;109:755\u201362.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3361_CR15","doi-asserted-by":"publisher","first-page":"e16976","DOI":"10.1371\/journal.pone.0016976","volume":"6","author":"AL Wilson","year":"2011","unstructured":"Wilson AL. A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS ONE. 2011;6:e16976.","journal-title":"PLoS ONE"},{"key":"3361_CR16","first-page":"CD003756","volume":"2","author":"MM Meremikwu","year":"2012","unstructured":"Meremikwu MM, Donegan S, Sinclair D, Esu E, Oringanje C. Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. Cochrane Database Syst Rev. 2012;2:CD003756.","journal-title":"Cochrane Database Syst Rev"},{"key":"3361_CR17","volume-title":"World malaria report 2018","author":"WHO","year":"2018","unstructured":"WHO. World malaria report 2018. Geneva: World Health Organization; 2018."},{"key":"3361_CR18","doi-asserted-by":"publisher","first-page":"e0166951","DOI":"10.1371\/journal.pone.0166951","volume":"11","author":"GD Antwi","year":"2016","unstructured":"Antwi GD, Bates LA, King R, Mahama PR, Tagbor H, Cairns M, et al. Facilitators and Barriers to uptake of an extended seasonal malaria chemoprevention programme in Ghana: a qualitative study of caregivers and community health workers. PLoS ONE. 2016;11:e0166951.","journal-title":"PLoS ONE"},{"key":"3361_CR19","doi-asserted-by":"publisher","first-page":"e0187460","DOI":"10.1371\/journal.pone.0187460","volume":"12","author":"R Compaor\u00e9","year":"2017","unstructured":"Compaor\u00e9 R, Yameogo MWE, Millogo T, Tougri H, Kouanda S. Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso. PLoS ONE. 2017;12:e0187460.","journal-title":"PLoS ONE"},{"key":"3361_CR20","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4269\/ajtmh.17-0599","volume":"98","author":"T Druetz","year":"2018","unstructured":"Druetz T, Corneau-Tremblay N, Millogo T, Kouanda S, Ly A, Bicaba A, et al. Impact evaluation of seasonal malaria chemoprevention under routine program implementation: a quasi-experimental study in Burkina Faso. Am J Trop Med Hyg. 2018;98:524\u201333.","journal-title":"Am J Trop Med Hyg"},{"key":"3361_CR21","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1038\/s41598-018-26474-6","volume":"8","author":"T Druetz","year":"2018","unstructured":"Druetz T. Evaluation of direct and indirect effects of seasonal malaria chemoprevention in Mali. Sci Rep. 2018;8:8104.","journal-title":"Sci Rep"},{"key":"3361_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12936-017-1974-x","volume":"16","author":"F Diawara","year":"2017","unstructured":"Diawara F, Steinhardt LC, Mahamar A, Traore T, Kone DT, Diawara H, et al. Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita. Mali Malar J. 2017;16:325.","journal-title":"Mali Malar J"},{"key":"3361_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/tmi.12642","volume":"21","author":"H Tagbor","year":"2016","unstructured":"Tagbor H, Antwi GD, Acheampong PR, Bart Plange C, Chandramohan D, Cairns M. Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial. Trop Med Int Health. 2016;21:224\u201335.","journal-title":"Trop Med Int Health"},{"key":"3361_CR24","doi-asserted-by":"publisher","first-page":"e1002175","DOI":"10.1371\/journal.pmed.1002175","volume":"13","author":"B Ciss\u00e9","year":"2016","unstructured":"Ciss\u00e9 B, Ba EH, Sokhna C, NDiaye JL, Gomis JF, Dial Y, et al. Effectiveness of seasonal malaria chemoprevention in children under ten years of age in Senegal: a stepped-wedge cluster-randomised trial. PLoS Med. 2016;13:e1002175.","journal-title":"PLoS Med"},{"key":"3361_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12936-019-2788-9","volume":"18","author":"RC Elliott","year":"2019","unstructured":"Elliott RC, Smith DL, Echodu DC. Synergy and timing: a concurrent mass medical campaign predicted to augment indoor residual spraying for malaria. Malar J. 2019;18:160.","journal-title":"Malar J"},{"key":"3361_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12936-016-1202-0","volume":"15","author":"EM Stuckey","year":"2016","unstructured":"Stuckey EM, Miller JM, Littrell M, Chitnis N, Steketee R. Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study. Malar J. 2016;15:148.","journal-title":"Malar J"},{"key":"3361_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12936-018-2305-6","volume":"17","author":"S Faye","year":"2018","unstructured":"Faye S, Cico A, Gueye AB, Baruwa E, Johns B, Ndiop M, et al. Scaling up malaria intervention \"packages\" in Senegal: using cost effectiveness data for improving allocative efficiency and programmatic decision-making. Malar J. 2018;17:159.","journal-title":"Malar J"},{"key":"3361_CR28","volume-title":"The PMI Africa IRS (AIRS) Project Indoor Residual Spraying (IRS 2) task order four. Mali: entomological monitoring of 2014 IRS activities final report","author":"PMI","year":"2014","unstructured":"PMI. The PMI Africa IRS (AIRS) Project Indoor Residual Spraying (IRS 2) task order four. Mali: entomological monitoring of 2014 IRS activities final report. Bethesda: AIRS Project, Abt Associates Inc; 2014."},{"key":"3361_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12936-015-0847-4","volume":"14","author":"MB Cisse","year":"2015","unstructured":"Cisse MB, Keita C, Dicko A, Dengela D, Coleman J, Lucas B, et al. Characterizing the insecticide resistance of Anopheles gambiae in Mali. Malar J. 2015;14:327.","journal-title":"Malar J"},{"key":"3361_CR30","doi-asserted-by":"publisher","first-page":"e0136919","DOI":"10.1371\/journal.pone.0136919","volume":"10","author":"AM Noor","year":"2015","unstructured":"Noor AM, Kibuchi E, Mitto B, Coulibaly D, Doumbo OK, Snow RW. Sub-national targeting of seasonal malaria chemoprevention in the Sahelian countries of the Nouakchott Initiative. PLoS ONE. 2015;10:e0136919.","journal-title":"PLoS ONE"},{"key":"3361_CR31","volume-title":"Enqu\u00eate D\u00e9mographique et de Sant\u00e9 au Mali 2012\u20132013","author":"Cellule de Planification et de Statistique (CPS\/SSDSPF)","year":"2014","unstructured":"Cellule de Planification et de Statistique (CPS\/SSDSPF), Institut National de la Statistique (INSTAT\/MPATP), INFO-STAT et ICF International. Enqu\u00eate D\u00e9mographique et de Sant\u00e9 au Mali 2012\u20132013. Rockville: CPS, INSTAT, INFO-STAT et ICF International; 2014."},{"key":"3361_CR32","volume-title":"The PMI Africa IRS (AIRS) Project Indoor Residual Spraying (IRS 2) task order four. 2014 Mali end of spray report","author":"PMI","year":"2014","unstructured":"PMI. The PMI Africa IRS (AIRS) Project Indoor Residual Spraying (IRS 2) task order four. 2014 Mali end of spray report. Bethesda: AIRS Project, Abt Associates Inc; 2014."},{"key":"3361_CR33","unstructured":"ACCESS-SMC: Mali. https:\/\/www.access-smc.org\/pages\/where-we-work\/mali. Accessed 10 Nov 2019."},{"key":"3361_CR34","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/aje\/kwr009","volume":"173","author":"TJ VanderWeele","year":"2011","unstructured":"VanderWeele TJ, Knol MJ. Remarks on antagonism. Am J Epidemiol. 2011;173:1140\u20137.","journal-title":"Am J Epidemiol"},{"key":"3361_CR35","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/infdis\/jiw416","volume":"214","author":"TP Eisele","year":"2016","unstructured":"Eisele TP, Bennett A, Silumbe K, Finn TP, Chalwe V, Kamuliwo M, et al. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on malaria in Southern Province Zambia: a cluster-randomized controlled trial. J Infect Dis. 2016;214:1831\u20139.","journal-title":"J Infect Dis"},{"key":"3361_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.14-0254","volume":"93","author":"G Newby","year":"2015","unstructured":"Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93:125\u201334.","journal-title":"Am J Trop Med Hyg"},{"key":"3361_CR37","first-page":"CD008846","volume":"12","author":"E Poirot","year":"2013","unstructured":"Poirot E, Skarbinski J, Sinclair D, Kachur SP, Slutsker L, Hwang J. Mass drug administration for malaria. Cochrane Database Syst Rev. 2013;12:CD008846.","journal-title":"Cochrane Database Syst Rev"},{"key":"3361_CR38","unstructured":"WHO. The role of mass drug adminstration, mass screening and treatment, and focal screening and treatment for malaria. Geneva: World Health Organization; 2015. https:\/\/www.who.int\/malaria\/publications\/atoz\/role-of-mda-for-malaria\/en\/. Accessed 6 Jan 2020."},{"key":"3361_CR39","volume-title":"Global strategic framework for integrated vector management","author":"WHO","year":"2014","unstructured":"WHO. Global strategic framework for integrated vector management. Geneva: World Health Organization; 2014."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-020-03361-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03361-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T23:13:16Z","timestamp":1628982796000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03361-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,15]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3361"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03361-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,15]]},"assertion":[{"value":"13 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research protocol was reviewed by the PATH Research Determination Committee and was determined not to meet the definition of research involving human subjects, per US Code of Federal Regulations 45 CFR 46 (PATH RDC#01026).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}